Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients

Project description

Inhibiting cellular 'stickiness' could cure pancreatic and ovarian cancers

Fields of science

• medical and health sciences › clinical medicine › cancer › colorectal cancer
• natural sciences › biological sciences › cell biology
• medical and health sciences › clinical medicine › cancer › pancreatic cancer
• medical and health sciences › basic medicine › immunology › immunotherapy

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

ELTHERA AG

Address

Brandstrasse 24
8952 Schlieren
Switzerland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 495 176,25